Gene therapy for neurological disorders: progress and prospects
Key findings
AAV9P31 engineered through peptide-display library screening for enhanced BBB penetration. Contains 7-amino acid insertion (WPTSYDA) in hypervariable region VIII. Uses carbonic anhydrase IV (CA-IV) receptor for BBB transcytosis. Demonstrated robust CNS transduction in mice but limited efficacy in NHP.